Christophe Jean Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

RYTM Quotes by TradingView

Christophe Jean is Director of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 7,000 shares of RYTM, which is worth approximately $691,950. The most recent transaction as insider was on Jun 18, 2025, when has been sold 4,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7K
133.33% 3M change
133.33% 12M change
Total Value Held $691,950

CHRISTOPHE JEAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2025
BUY
Exercise of conversion of derivative security
-
4,000 Added 36.36%
7,000 Common Stock
Jun 21 2024
BUY
Exercise of conversion of derivative security
-
3,000 Added 50.0%
3,000 Common Stock
CJ

Christophe Jean

Director
Boston, MA

Track Institutional and Insider Activities on RYTM

Follow RHYTHM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RYTM